- Q1 2024 Humacyte Inc Earnings Call TranscriptMay 10, 2024$4.7 (+3.98%)Earnings
- Q4 2023 Humacyte Inc Earnings Call TranscriptMar 22, 2024$3.31 (-8.06%)Earnings
- Q3 2023 Humacyte Inc Earnings Call TranscriptNov 09, 2023$2.21 (+0.91%)Earnings
- Humacyte Inc To Host KOL And Patient Perspectives Event TranscriptSep 20, 2023
- Humacyte Inc Top Line Data Announcement TranscriptSep 12, 2023
- Q2 2023 Humacyte Inc Earnings Call TranscriptAug 14, 2023$4.04 (+23.55%)Earnings
- Q1 2023 Humacyte Inc Earnings Call TranscriptMay 12, 2023$3.97 (-6.48%)Earnings
- Humacyte Inc at H.C. Wainwright BioConnect Investor Conference TranscriptMay 02, 2023
- Q4 2022 Humacyte Inc Earnings Call TranscriptMar 24, 2023$2.91 (-5.83%)Earnings
- Humacyte Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 14, 2023
- Humacyte Inc at Cowen Health Care Conference TranscriptMar 06, 2023
- Humacyte Inc At Emerging Growth Conference (Virtual) TranscriptFeb 08, 2023
- Humacyte Inc KOL Webinar: Ukrainian Surgeons Discuss Use of HAV in Wartime TranscriptDec 15, 2022
- Q3 2022 Humacyte Inc Earnings Call TranscriptNov 10, 2022$3.26 (+3.82%)Earnings
- Q4 2021 Humacyte Inc Earnings Call TranscriptMar 29, 2022$6.73 (+5.65%)Earnings
Q1 2023 Humacyte Inc Earnings Call Transcript
Good morning, ladies and gentlemen, and welcome to the Humacyte First Quarter Results Conference Call. (Operator Instructions). As a reminder, this conference call is being recorded.
I'll now turn the call over to Lauren Marek with LifeSci Advisors. Please go ahead.
Thank you, operator. Before we proceed with the call, I would like to remind everyone that certain statements made during this call are forward-looking statements under U.S. federal securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. Additional information concerning factors that could cause actual results to differ from statements made on this call is contained in our periodic reports filed with the SEC. The forward-looking statements made during this call speak only as of the date hereof, and the company undertakes no obligation to update or revise the forward-looking statements, except as required by law. Information presented on this call is contained in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)